Evidence map›Paper›PMID 37764293›Full record

ArticleMolecules (Basel, Switzerland)2023

Functional Characterization and Anti-Tumor Effect of a Novel Group II Secreted Phospholipase A

Mona Alonazi, Najeh Krayem, Mona G Alharbi, Arwa Ishaq A Khayyat, Humidah Alanazi, Habib Horchani, Abir Ben Bacha

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Mona AlonaziBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0002-9430-7980
Najeh KrayemLaboratoire de Biochimie et de Génie Enzymatique des Lipases, ENIS, Université de Sfax, Route de Soukra 3038, Sfax BP 1173, Tunisia.
Mona G AlharbiBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Arwa Ishaq A KhayyatBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0003-3376-7008
Humidah AlanaziBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0002-2079-7577
Habib HorchaniScience Department, College of Rivière-Du-Loup, Rivière-Du-Loup, QC G5R 1R1, Canada.
Abir Ben BachaBiochemistry Department, Science College, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.ORCID 0000-0001-6372-7483
King Saud University · SACégep de Rivière-du-Loup · CAUniversity of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secreted phospholipases A

Indexed as

Antineoplastic AgentsViperidaeAnimalsGroup II Phospholipases A2HumansPhospholipasesPhospholipases A2Saudi ArabiaViper VenomsAntineoplastic AgentsGroup II Phospholipases A2PhospholipasesPhospholipases A2Viper Venomsanti-tumor effectcytotoxicityhuman cancer cell linessecreted phospholipase A2snake venomstability

Identifiers

PMID37764293
PMCPMC10536776
OpenAlexW4386546997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.